Quadrant Capital Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-334
| Closed | -$6.06K | – | 1594 |
|
|
2025
Q1 | $6.06K | Buy |
334
+267
| +399% | +$4.85K | ﹤0.01% | 2320 |
|
|
2024
Q4 | $1.69K | Buy |
+67
| New | +$1.69K | ﹤0.01% | 2516 |
|
|
2022
Q3 | – | Sell |
-132
| Closed | -$4K | – | 2653 |
|
|
2022
Q2 | $4K | Buy |
+132
| New | +$4K | ﹤0.01% | 2022 |
|
|
2016
Q1 | – | Sell |
-25
| Closed | -$5K | – | 1827 |
|
|
2015
Q4 | $5K | Buy |
+25
| New | +$5K | ﹤0.01% | 1077 |
|